Powder Delivery TRIZ Cases

A dual-phase, pH-dependent gamma-hydroxybutyrate formulation improves bioavailability for once-nightly dosing while lowering sodium intake.

Cyclodextrin inclusion complexes turn PARP inhibitors into fast-dissolving injectable formulations with higher bioavailability for shock and cancer treatment.

Defined HPMC powder particle sizes help nasal gels trap allergens and viruses longer while still allowing drug diffusion across mucosa.

A peptide-grafted nanocomposite redirects pathogenic proteins into autophagy, enabling degradation of large aggregates and cytoplasmic targets.

Ambient-stable nucleic acid vaccine formulations use LNP delivery and stabilizing components to preserve SARS-CoV-2 immune protection without cold storage.

Micro-fragmented fat tissue enables rapid drug loading and sustained local release while preserving biological activity and minimizing toxicity.

Porous lyophilized ceramic-polymer macroparticles absorb fluid evenly to prevent clumping, maintain flowability, and avoid syringe clogging.

A porous sorbent with Polysorbate 80 improves oral cannabinoid solubility, stability, and delayed intestinal release.

pH-responsive nanoparticles release copper or silver in biofilm-laden wounds, improving antimicrobial delivery while supporting healing.

Gas-phase ozone is trapped during crystallization to deliver antimicrobial action in porous or crystalline solids with lower energy and simpler equipment.

Micronized PDE4 inhibitor and lactose carrier particles maintain respirable delivery without magnesium stearate, reducing systemic exposure.

A dual-phase gamma-hydroxybutyrate release profile improves bioavailability and enables once-nightly dosing with fewer adverse reactions.

Mesoporous nano-magnesium oxide uses controlled particle size and 2-20 nm pores to improve drug loading while reducing carrier toxicity.

Histidine acetate buffer with trehalose and mannitol stabilizes recombinant galectin-9 against denaturation, oxidation, aggregation, and degradation.

A mushroom extract blend blocks SARS-CoV-2 Spike S1 binding to ACE2, enabling oral or topical antiviral prevention beyond injections.

A combined CFTR corrector and potentiator improves ion transport and reduces mucus buildup in cystic fibrosis treatment.

Pulmonary delivery of apremilast, ibudilast, or crisaborole bypasses digestive degradation and first-pass metabolism to improve IPF treatment.

A ternary lactose capsule blend improves respirable tanimilast delivery while limiting agglomeration and systemic absorption.

Nested liposome and modified chitosan encapsulation protects probiotics in goat colostrum powder, improving survival during storage and digestion.

Buffer, saccharide, and surfactant combinations stabilize bispecific anti-CD3/CD20 formulations against heat, shear, and aggregation.

Purified pollen particles remove the lipid layer to improve mucosal adhesion, penetration, and controlled nanosystem release.

Specific lactams disrupt quorum sensing and biofilm formation in chronic respiratory infections, including cystic fibrosis and resistant strains.

A ternary blend of sodium citrate, citric acid, and sucralose masks API bitterness while dissolving quickly without residue.

Controlled sodium, Si/Zr ratio, and impurity removal make zirconium silicate safer for long-term potassium removal with low lead.

An implantable porous scaffold improves lymphocyte trafficking and persistence near tumors to clear residual cells and help prevent relapse.

Short ECM-binding peptides target FN-EDB and TNC-C to improve tumor drug delivery and imaging without the cost and penetration limits of antibodies.

Polymer-lipid hybrid nanoparticles use PLGA, PEI, and MC3 to preserve non-viral transfection efficiency and shelf stability with low immune response.

Mono-unsaturated ionizable lipids and anionic phospholipids improve LNP oxidative stability while preserving dendritic cell mRNA transfection.

An amorphous cannabinoid dispersed with a high-monoester sucrose fatty acid ester and water-soluble polymer improves water solubility and oral absorption.

DNA branched origami with LL37 peptide complexation improves peptide vaccine delivery, antigen presentation, and IV stability.

A self-assembling KARI nanoparticle presents multiple antigens on one scaffold to strengthen and prolong immune responses across viral variants.

Phospholipid-coated sivelestat particles enable stable inhaled dry powder with sustained lung retention, high local exposure, and simpler production.

Milled Boswellia and curcuminoid particles dispersed in sesame oil improve oral bioavailability and reduce high-dose drug wastage.

A buffered surfactant-stabilizer formulation keeps anti-CSF-1R antibodies stable at high concentration for filter-free IV use.

Freeze-dried calpain probe formulations improve water solubility and storage stability, enabling practical reconstitution for clinical administration.

Acid-producing bacterial blends lower oral pH and suppress volatile sulfur compounds, improving halitosis control in alkaline conditions.

A mixed radioactive and non-radioactive microparticle composition improves tumor coverage while preserving real-time imaging for SIRT dose planning.

Antibody-coated silica-gold nanoparticles bind HER2 and CD3 to steer CAR-T cells to solid tumors with faster treatment and lower off-target risk.

Plasminogen pathway activators raise SMN protein expression and help protect motor neurons and lung function in spinal muscular atrophy.

Alternating-polarity magnets attract nanoparticle-bound stone fragments, enabling simultaneous urinary tract retrieval with less operative time.

Freeze-dried tubulysin analog conjugates improve storage stability and shipment while lowering liver toxicity in targeted treatment.

SpyCatcher-coated cell-membrane nanoparticles speed ligand attachment while preserving functionality for scalable targeted payload delivery.

Phosphatidylserine and mono-unsaturated ionizable lipids improve LNP oxidative stability while maintaining strong dendritic cell transfection.

A DSPC-DPPG-Na-PEG4000-palmitic acid microbubble powder improves reconstituted stability, pressure resistance, and ultrasound signal retention.

Selective scavengers remove alkyl halides and aldehydes from ionizable lipids without column chromatography, protecting mRNA in LNPs.

Directional Fc-linked antibodies on iron nanoparticles enable local PD-L1 immunotherapy in HCC with stronger tumor binding and fewer irAEs.

Hypoxia-primed MSC-derived ECM with dextran sulfate forms insoluble microparticles that boost angiogenesis and speed chronic wound closure.

Angled sealed edges help an oral pouch conform between the gums and cheek, improving comfort without relying on simple perpendicular seals.

Annealing drug-polymer mixtures with an adjuvant plasticizer accelerates molecular diffusion, reducing thermal degradation risks.

Antibody-linked DNA dendrimers facilitate endocytic uptake and pH-triggered cytosolic release, preventing lysosomal degradation of therapeutic cargoes.

A multi-layered lamellar granule encapsulates ceramides within a nucleating agent core and polymer overcoat to deliver stable skin moisturization.

Nested torsion springs provide progressive load resistance in seatbelt retractors, managing occupant energy absorption across varying body sizes.

Functionalizing quantum dot surfaces with reactive groups enables stable covalent peptide bonding for bioconjugation.

Segmented single-use cartridges eliminate preservatives while inert atmosphere minimizes evaporative losses during precise pulmonary delivery.

Reversible covalent bonds maintain T lymphocyte viability and anti-tumor activity while preventing bioactivity loss during systemic delivery.

Engineering nanoparticle protein coronas converts harmful immunotoxicity into beneficial anticancer therapy by activating macrophages and neutrophils.

A noble metal nanorod paired with an upconversion phosphor enables simultaneous optical detection and thermal ablation of targeted cancer cells.

Liquid-activated bioadhesive strip seals periodontal wounds, resolving moisture saturation and adhesion reliability issues.

Segmenting delivery via oral beraprost and inhaled treprostinil reduces systemic side effects while maintaining therapeutic efficacy.

Micromolding forms uniform macroporous chitosan-polyacrylamide hydrogel microspheres via surface tension and photopolymerization.

Sorbitol and PEG ratios prevent protein aggregation without adding complex lyoprotectants.

Controlled hydraulic pressing of agglomerated trichomes and pre-treated biomass ensures uniform cannabinoid distribution.

Inhaled trehalose bypasses gastrointestinal degradation, resolving the contradiction between non-invasive administration and therapeutic effectiveness.

Photo-crosslinked biocompatible polymers form temperature-sensitive nano-carriers with reversible size changes.

siRNA delivery vehicles knock down TWIST1 expression to reverse chemotherapy resistance and inhibit metastasis in triple-negative breast cancer.

A heterologous immunogenic composition encodes a DMV/1639 spike protein to induce protective immunity in poultry.

A sterile de-cellularized human amniotic fluid formulation containing over 300 growth factors reduces joint pain and promotes cartilage regeneration.

Copper sulfide nanoparticles replace expensive gold particles, enabling cost-effective photothermal ablation of small tumors through simple chemical synthesis.

SapC-DOPS nanovesicles elevate ceramide levels to destroy solid tumors, overcoming inadequate targeting of current cancer therapies.

Myoglobin nanoparticles induce tumor-specific microvascular embolization, resolving hypoxia and enhancing radiation sensitivity.

Nanoparticulate policosanol resolves inconsistent lipid-lowering results by using stabilized particles under 100 nm to improve bioavailability.

X-ray absorbing nanostructures convert penetrating x-rays into near-infrared light, enabling deep-tissue cancer treatment without invasive procedures.

Replacing sugar excipients with specific amino acids prevents dimer formation and reduces viscosity in high-concentration antibody formulations.

Clathrin nanoparticles enable non-invasive delivery of brain-derived neurotrophic factor across the blood-brain barrier, avoiding invasive procedures.

Functionalized carrier particles adsorb drug nanoparticles to enable simple filtration isolation while preserving fast dissolution rates.

Segmented reservoirs and flexible membranes maintain stable drug concentrations in the mouth, reducing side effects from concentration fluctuations.

Oral ergothioneine suppresses age-related hearing loss progression by reducing oxidative stress in the inner ear.

Segmented blending stages tune aerodynamic diameter for precise pulmonary delivery while preventing ingredient interactions.

Uranium ore radiation processes medicinal agents into 2-6 nm particles that selectively embolize tumor microvasculature while sparing normal tissue.

A ferrisilicate insulin composite enables sustained oral delivery of peptide hormones.

Homogenizing a mixture of phospholipids, non-ionic surfactants, and cyclosporine A creates a stable colloidal solution that addresses low aqueous solubility.

A phosphate-citrate buffer system maintains Etanercept activity during long-term storage.

Low dose phytic acid administration prevents beta amyloid protein aggregation in brain tissue.

Tunable surface density of amphiphilic macromolecules enables sustained drug release at mucosal sites without compromising particle stability.

Replacing antigen-antibody systems with ligand-receptor coupling eliminates racial specificity and immunogenicity while maintaining high targeting efficiency.

A structured treatment cycle administers Compound A in defined intervals to maximize antineoplastic activity.

Targeted nanoparticles with optimized chelating groups capture copper and iron in tumors, reducing systemic side effects from non-specific metal binding.

Co-precipitation creates homogeneous PEG adhesive blends by controlling solvent conditions to ensure uniform therapeutic agent distribution.

Polyacrylamide-based nanostructured carriers resolve the contradiction between nucleic acid protection and cytotoxicity through controlled polymer substitution.

A method loads drugs into AAV empty capsids using controlled heating to preserve infection activity.

SAPLIP nanodiscs replace detergent micelles to solubilize membrane proteins while preserving biological activity and biocompatibility.

Salt solubility changes and emulsion processing reduce burst effect and degradation in controlled release formulations.